Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C

Transpl Int. 2006 Feb;19(2):170-1. doi: 10.1111/j.1432-2277.2005.00242.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Hepatitis C / drug therapy*
  • Hepatitis C / etiology
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Liver Transplantation / adverse effects
  • Male
  • Middle Aged
  • Mycophenolic Acid / administration & dosage
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives*
  • Recurrence
  • Red-Cell Aplasia, Pure / blood
  • Red-Cell Aplasia, Pure / chemically induced*
  • Ribavirin / administration & dosage
  • Ribavirin / adverse effects*

Substances

  • Antiviral Agents
  • Immunosuppressive Agents
  • Ribavirin
  • Mycophenolic Acid